Patents by Inventor Wlodek Mandecki

Wlodek Mandecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6361950
    Abstract: Disclosed are materials and methods for performing multiplex assays for nucleic acids, in which a transponder is associated with the bead(s) forming the solid phase used in the assay, nucleic acid probes are bound to the surface of the particles, and data concerning the assay is encoded on the transponder. A dedicated read/write device is used to remotely encode or read the data.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: March 26, 2002
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Publication number: 20020006673
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders associated with the bead(s) used as the solid phase in the assay, and information pertinent to the assay is encoded on the transponders memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Application
    Filed: July 17, 2001
    Publication date: January 17, 2002
    Applicant: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Publication number: 20010044109
    Abstract: A method is described for determining the sequence of nucleic acids. The method employs small solid phase particles having transponders, with a primary layer of an oligonucleotide of known sequence attached to the outer surface of the particle. A read/write scanner device is used to encode and decode data on the transponder. The stored data includes the sequence of the oligonucleotide immobilized on the transponder. The sequence of sample nucleic acids is determined by detecting annealing to an oligonucleotide bound to a particle, followed by decoding the transponder to determine the sequence of the oligonucleotide.
    Type: Application
    Filed: February 12, 2001
    Publication date: November 22, 2001
    Applicant: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6051377
    Abstract: Disclosed are materials and methods for performing multiplex assays for nucleic acids, in which a transponder is associated with the bead(s) forming the solid phase used in the assay, nucleic acid probes are bound to the surface of the particles, and data concerning the assay is encoded on the transponder. A dedicated read/write device is used to remotely encode or read the data.
    Type: Grant
    Filed: December 9, 1996
    Date of Patent: April 18, 2000
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6046003
    Abstract: A method is described for determining the sequence of nucleic acids. The method employs small solid phase particles having transponders, with a primary layer of an oligonucleotide of known sequence attached to the outer surface of the particle. A read/write scanner device is used to encode and decode data on the transponder. The stored data includes the sequence of the oligonucleotide immobilized on the transponder. The sequence of sample nucleic acids is determined by detecting annealing to an oligonucleotide bound to a particle, followed by decoding the transponder to determine the sequence of the oligonucleotide.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: April 4, 2000
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6001571
    Abstract: Disclosed are materials and methods for performing multiplex assays for nucleic acids, in which a transponder is associated with the bead(s) forming the solid phase used in the assay, nucleic acid probes are bound to the surface of the particles, and data concerning the assay is encoded on the transponder. A dedicated read/write device is used to remotely encode or read the data.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: December 14, 1999
    Inventor: Wlodek Mandecki
  • Patent number: 5981166
    Abstract: The invention provides a method to rapidly screen chemical compounds by delivering the compounds to the assay as a coating on transponders, rather than as powder or solution. The transponder's function is to store data that identify the compound. The data can be decoded in any moment of the assay, and the identity of the desired compound established.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: November 9, 1999
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 5736332
    Abstract: A method is described for determining the sequence of nucleic acids. The method employs small solid phase particles having transponders, with a primary layer of an oligonucleotide of known sequence attached to the outer surface of the particle. A read/write scanner device is used to encode and decode data on the transponder. The stored data includes the sequence of the oligonucleotide immobilized on the transponder. The sequence of sample nucleic acids is determined by detecting annealing to an oligonucleotide bound to a particle, followed by decoding the transponder to determine the sequence of the oligonucleotide.
    Type: Grant
    Filed: November 30, 1995
    Date of Patent: April 7, 1998
    Inventor: Wlodek Mandecki
  • Patent number: 5641634
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders having memory elements associated with particle(s) used as a solid phase in art assay, and information pertinent to the assay is encoded on the transponder memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information encoded on the transponder memory elements. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Grant
    Filed: November 30, 1995
    Date of Patent: June 24, 1997
    Inventor: Wlodek Mandecki
  • Patent number: 4936963
    Abstract: The present invention provides for polycationic buffers for the gel electrophoresis of and methods for obtaining improved separation and resolution of nucleic acids. In particular, the invention provides for a buffer consisting essentially of histidine for the gel electrophoresis of oligonucleotides ranging from a few to about 70 nucleotides in length. Polycationic buffers may be used for both analytical and preparative purposes and result in a nearly two-fold improvement in both separation and resolution of the nucleic acid bands. Furthermore, the use of polycationic buffers reduces the electrophoresis time by a factor of about three due to the low conductivity of the buffers.
    Type: Grant
    Filed: May 23, 1989
    Date of Patent: June 26, 1990
    Assignee: Abbott Laboratories
    Inventors: Wlodek Mandecki, Mark A. Hayden